Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FG-2216: Phase I data

In a German Phase I trial in hemodialysis patients and healthy volunteers, single doses

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE